Home Page

Personalized Medicine: Our Mission

The Center for Applied Proteomics and Molecular Medicine’s (CAPMM) mission is to:

  • Create new technologies and make basic science discoveries in the field of disease pathogenesis
  • Apply these discoveries and technologies to create and implement strategies for disease prevention, early diagnosis and individualized therapy.

The primary emphasis of our disease research is cancer, but new technologies developed in the center are being applied to a number of important human diseases including cardiovascular disease, diabetes, and obesity, as well as liver, ocular, neurodegenerative and infectious diseases.

Personalized medicine strives to provide the right medicine for the right patient with the lowest toxicity. Research, like that being done by the Center for Applied Proteomics and Molecular Medicine, provides strategies for personalized treatment with the goal of providing physicians key missing molecular information about the disease in each of their patients and improving the quality of life for patients.

CAPMM: Research Highlight

Mason’s Successful Moonshot: A Saliva-Based COVID-19 Test

During National Public Health Week, we revisit the development and application of the PCR saliva test that allowed Mason’s Laboratory for Advanced Testing to analyze 10,000 tests a week at the height of the COVID pandemic and positioned Mason to be at the forefront of the next diagnostic challenge.

Research and Technology

Personalized medicine strives to provide the right medicine for the right patient with the lowest toxicity. Take a minute to view all the progress our team is doing in the field of Personalized Medicine.

View all of our research:

Publications

View all published works over the years from our dedicated research teams.

View Publications:

Educational Advancement

Are you a graduate student or undergraduate looking for way to work with CAPMM, or the courses the researchers from our program teach?

View all Education information:

Recent News

View all CAPMM News